Rhythm Express Wearable System vs. Simultaneous Polysomnography for the Diagnosis of Obstructive Sleep Apnea in Adults With Suspected or Observed Atrial Fibrillation

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 18, 2024

Primary Completion Date

June 16, 2025

Study Completion Date

June 25, 2025

Conditions
Obstructive Sleep Apnea (OSA)Atrial Fibrillation (Paroxysmal)Palpitations
Interventions
DEVICE

Rhythm Express Wearable System

The Rhythm Express Wearable System consists of the FDA-cleared RX-1 mini Cardiac Monitor, an FDA-cleared pulse oximeter, and a cellular gateway to relay data from the pulse oximeter to the cloud-based RS-1 Server. The RS-1 Sleep Algorithm is a cloud-based software as a medical device (SWMD) that receives inputs from the two FDA-cleared wearable devices. The Algorithm, together with the two wearable devices, comprises the Rhythm Express Wearable System.

Trial Locations (4)

28287

Javara - Tryon Medical Partners, PLLC, Charlotte

54449

Marshfield Clinic Research Institute, Marshfield

63123

Clayton Sleep Institute, St Louis

72032

Central Arkansas Lung- J&L Research, Conway

Sponsors

Lead Sponsor

All Listed Sponsors
lead

VivaQuant

INDUSTRY

NCT06907888 - Rhythm Express Wearable System vs. Simultaneous Polysomnography for the Diagnosis of Obstructive Sleep Apnea in Adults With Suspected or Observed Atrial Fibrillation | Biotech Hunter | Biotech Hunter